BONESUPPORT AB

BONESUPPORT AB is a Scandinavian orthobiologics company specializing in the development and commercialization of injectable bone regeneration products. The company's primary product line is CERAMENT®, an innovative range of radiopaque, osteoconductive, drug-eluting bioceramic materials designed for bone defect healing and regeneration. CERAMENT products are formulated as injectable bioceramics that remodel to host bone over a six- to twelve-month period, providing a resorptive scaffold for natural bone healing. The company's product portfolio addresses clinical indications including trauma-related bone defects, infection-related bone loss (chronic osteomyelitis), benign bone tumors, and bone voids resulting from surgical intervention. CERAMENT products combine osteoconductivity with drug-eluting capability, enabling antimicrobial or other therapeutic agent delivery. The company markets these products to orthopedic surgeons, trauma surgeons, and orthopedic hospitals across European and international markets. BONESUPPORT is a publicly listed company (BONESUPPORT HOLDING AB, publ), indicating regulatory compliance and transparency standards consistent with major healthcare market requirements. The company's regulatory positioning supports compliance with CE marking for European markets and pursuit of additional regulatory pathways.